Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Tuberculosis Has Shaped Medicine and Society

Simon M. Helfgott, MD  |  Issue: May 2017  |  May 17, 2017


Simon M. Helfgott, MDSimon M. Helfgott, MD, is associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School in Boston.

References

  1. Terry SI, Hanchard B. Gastrology: The use of culinary terms in medicine. Br Med J. 1979 Dec 22–29;2(6205):1636–1639.
  2. Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med. 2012 Sep 6; 367(10):931–936.
  3. Mitchison DA. The diagnosis and therapy of tuberculosis during the past 100 years. Am J Respir Crit Care Med. 2005 Apr 1;171(7):699–706.
  4. Mackowiak PA, Tiesler Blos V, Aguilar M, et al. On the origin of American tuberculosis. Clin Infect Dis. 2005 Aug 15;41(4):515–518.
  5. Comas I, Coscolla M, Luo T, et al. Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013 Oct;45(10):1176–1182.
  6. Smith NH, Hewinson RG, Kremer K, et al. Myths and misconceptions: The origin and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol. 2009 Jul;7(7):537– 544.
  7. Herr HW, Morales A. History of Bacillus Calmette-Guerin and bladder cancer: An immunotherapy success story. J Urol. 2008 Jan;179(1):53–56.
  8. Luca S, Mihaescu T. History of BCG vaccine. MAEDICA (Buchar). 2013 Mar;8(1):53–58.
  9. Pearl R. Cancer and tuberculosis. Am J Hygiene. 1929 Jan;9:97–159.
  10. Old LJ, Clarke DA, Benacerraf B. Effect of bacillus Calmette-Guerin infection on transplanted tumours in the mouse. Nature. 1959 Jul 25;184(Suppl 5):291–292.
  11. Carswell EA, Old LJ, Kassell RJ, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Nat Acad Sci. 1975 Sep;72(9):3666–3670.
  12. Rasmussen N. Freund’s adjuvant and the realization of questions in postwar immunology. Hist Stud Phys Biol Sci. 1993;23(2):337–366.
  13. Kopeloff L, Kopeloff N. The production of antibrain antibody in the monkey. J Immunol. 1944 May 1;48(5):297–304.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Caseation necrosisHistoryImmunologyrheumatologistrheumatologyTreatmentTuberculosis

Related Articles

    ASIA: A New Way to Put the Puzzle Together

    June 13, 2011

    Autoimmune (autoinflammatory) syndrome induced by adjuvants provides a diagnostic framework for enigmatic conditions

    Chronic Reactive Arthritis Secondary to Intravesical Bacillus Calmette–Guerin in Bladder Carcinoma

    September 8, 2016

    A 50-year-old man with history of superficial bladder carcinoma presented to our rheumatology clinic for a three-year history of symmetric polyarthralgias. He had undergone multiple transurethral resection of bladder tumor procedures and bacillus Calmette–Guerin (BCG) treatments. Prior to receiving BCG, he was fully functional and employed. Days after receiving his second BCG treatment, he developed…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Case Report: A Non-Tuberculous Mycobacterial Infection

    January 20, 2021

    Tumor necrosis factor-α inhibitors (TNFi’s) have emerged as an integral part of therapeutic strategies for several rheumatic diseases. TNF-α is a pro-inflammatory cytokine implicated in the pathogenesis of rheumatoid arthritis (RA), seronegative spondyloarthropathies and inflammatory bowel disease (IBD). It also plays a central role in the immune response to mycobacterial infection.  Many biologic agents, particularly…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences